A Selective Role of Dietary Anthocyanins and Flavan-3-ols in Reducing the Risk of Type 2 Diabetes Mellitus: A Review of Recent Evidence - PubMed (original) (raw)

Review

A Selective Role of Dietary Anthocyanins and Flavan-3-ols in Reducing the Risk of Type 2 Diabetes Mellitus: A Review of Recent Evidence

Britt Burton-Freeman et al. Nutrients. 2019.

Abstract

Type 2 diabetes mellitus (T2DM) is the most common form of DM and its prevalence is increasing worldwide. Because it is a progressive disease, prevention, early detection and disease course modification are possible. Diet plays a critical role in reducing T2DM risk. Therapeutic dietary approaches routinely recommend diets high in plant foods (i.e., vegetables, fruits, whole-grains). In addition to essential micronutrients and fiber, plant-based diets contain a wide-variety of polyphenols, specifically flavonoid compounds. Evidence suggests that flavonoids may confer specific benefits for T2DM risk reduction through pathways influencing glucose absorption and insulin sensitivity and/or secretion. The present review assesses the relationship between dietary flavonoids and diabetes risk reduction reviewing current epidemiology and clinical research. Collectively, the research indicates that certain flavonoids, explicitly anthocyanins and flavan-3-ols and foods rich in these compounds, may have an important role in dietary algorithms aimed to address diabetes risk factors and the development of T2DM.

Keywords: diabetes; flavonoids; glucose; glycemic control; insulin; polyphenols.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1

Path to Diabetes/T2DM: A. normal, non-disease/diabetes state (based on fasting glucose 70–99 mg/dL). B. declining insulin sensitivity/increasing insulin resistance, and increasing concentrations of insulin (hyperinsulinemia) to maintain normal glucose: Opportunity * for early detection and intervention to restore normal insulin sensitivity and decrease beta cell burden. C. pre-diabetes identified (fasting glucose 100–125 mg/dL, [1], hyperinsulinemia insufficient to overcome insulin resistance. Diet and lifestyle intervention prescribed. D. T2DM diagnosed (fasting glucose ≥126 mg/dL or 2-h post glucose ≥140 mg/dL, [1], diet and lifestyle and medications prescribed.

Figure 2

Flavonoid compounds, dietary sources and daily intake range. 1 Aglycone values [25].

Figure 3

Purported mechanisms of action of flavonoids with effects on glucose metabolism: AMPK, AMP-activated protein kinase; CHO, carbohydrate; GK, Glucokinase; GLUT 4, Glucose transporter type 4; GNG, Gluconeogenesis; GS, Glutamine synthetase; IRS-1, Insulin receptor substrate 1; JNK, c-Jun N-terminal kinases; Ox, Oxidative; PI3/AKT, phosphatidylinositol 3-kinase (PI3K) and AKT/Protein Kinase B signaling pathway; SGLT, Sodium-dependent glucose transporter; (+), increase, activation; (−), decrease, inactivation.

References

1. American Diabetes Association 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018. Diabetes Care. 2018;41:S13–S27. doi: 10.2337/dc18-S002. - DOI - PubMed
1. Mathers C.D., Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med. 2006;3:e442. doi: 10.1371/journal.pmed.0030442. - DOI - PMC - PubMed
1. Gregg E.W., Li Y., Wang J., Rios Burrows N., Ali M.K., Rolka D., Williams D.E., Geiss L. Changes in Diabetes-Related Complications in the United States, 1990–2010. N. Engl. J. Med. 2014;370:1514–1523. doi: 10.1056/NEJMoa1310799. - DOI - PubMed
1. Cho N., Shaw J., Karuranga S., Huang Y., Fernandes J.D.R., Ohlrogge A., Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 2018;138:271–281. doi: 10.1016/j.diabres.2018.02.023. - DOI - PubMed
1. World Health Organisation . Mortality and Burden of Disease Attributable to Selected Major Risks. World Health Organisation; Geneva, Switzerland: 2009.

A Selective Role of Dietary Anthocyanins and Flavan-3-ols in Reducing the Risk of Type 2 Diabetes Mellitus: A Review of Recent Evidence - PubMed (original) (raw)